Patent Consent Policy
Patent Consent Policy
TMP Universal Journal of Advances in Pharmaceutical Sciences values innovation and the protection of intellectual property in pharmaceutical research. The Patent Consent Policy ensures that the intellectual property rights of authors are respected and properly handled during the submission and publication process.
- Disclosure of Patents
- Authors submitting manuscripts to TMP Universal Journal of Advances in Pharmaceutical Sciences are required to disclose any existing patents, pending patent applications, or any other intellectual property claims related to the content of the manuscript.
- This disclosure must include information about the patent number, title, and status (pending, granted, or abandoned) and should be made during the manuscript submission process.
- Patent Rights
- Authors' Rights: Authors maintain the rights to their patents, including the right to pursue patent protection through appropriate legal channels. Publication in the journal does not affect an author’s right to file a patent or pursue patent protection.
- Journal's Role: The journal does not claim ownership of any patents or intellectual property rights in the submitted manuscripts. However, the journal requests that the authors acknowledge that their work is not infringing upon existing patents or intellectual property owned by others.
- Patent and Publication Timeline
- It is advised that authors file for patent protection prior to submitting their manuscript for publication in the journal. If an article contains patentable material, the authors should seek advice from a patent attorney or their institution’s patent office to ensure that their intellectual property is protected before the manuscript is made publicly available.
- Authors should be aware that once a manuscript is published in an open-access journal, the content becomes publicly available. Therefore, patent filings should be made in advance of publication to prevent the loss of patent rights due to public disclosure.
- Patent Consent for Publication
- If an article involves patentable material or an invention that is under patent review, authors are required to provide written consent for publication, acknowledging that they are aware of the potential impact of public disclosure on their patent rights.
- The manuscript should include a clear statement about the consent for publication of the patentable material and any related intellectual property concerns.
- Ethical Considerations
- Authors must ensure that the submission does not violate the patent rights of others. Any submission that is found to infringe on existing patents or intellectual property will be subject to rejection.
- The journal encourages authors to be transparent about any ongoing intellectual property disputes or claims related to the content of their manuscript.
- Patent Disputes and Liability
- TMP Universal Journal of Advances in Pharmaceutical Sciences does not assume responsibility for any patent disputes arising from the content published in the journal. Authors are solely responsible for ensuring that their submissions do not infringe on any existing patents or intellectual property rights.
- In the event of a patent dispute, the authors agree to hold the journal harmless and indemnify the journal from any legal claims, damages, or costs that may arise due to patent infringements associated with their submitted or published content.
- Intellectual Property Protection for Authors
- Authors are encouraged to work with their institution’s technology transfer office or legal counsel to protect their intellectual property rights before submission and publication.
- The journal provides a platform for the dissemination of research findings but does not engage in patenting or licensing activities on behalf of the authors.
